Drawing for PEDEMED

USPTO serial 79410417

PEDEMED

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
THOMAS, JULIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PEDEMED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander P. Montgomery

Alexander P. Montgomery Hinckley Allen & Snyder LLP28 State StreetBoston, MA 02109United States

Goods and services

ClassDescriptionStatusFirst use
009Recorded software for accessing information and instructions for the preparation of parenteral drugs and calculating medication dosage for healthcare professionals; downloadable software for accessing information and instructions for the preparation of parenteral drugs and calculating medication dosage for healthcare professionals; recorded database management software; downloadable database management software; recorded application software for accessing information and instructions for the preparation of parenteral drugs and calculating medication dosage for healthcare professionals; downloadable application software for accessing information and instructions for the preparation of parenteral drugs and calculating medication dosage for healthcare professionalsACTIVE—
035Updating and maintenance of data in computer databases; data processing services; compilation and systematization of information into computer databases; data compilation and entry in computer databasesACTIVE—
042Software as a service (SaaS) featuring software for accessing information and instructions for the preparation of parenteral drugs, validation and preparation of medicines, and calculating medication dosage for healthcare professionals; providing advice and information services with respect to software; creation, maintenance and updating of software; installation, repair and maintenance of software; installation, maintenance and updating of database software; hosting of software applications for others; programming of software for importing and managing data; temporary provision online of non-downloadable software for database management; providing temporary use of online, non-downloadable software applications for accessing information and instructions for the preparation of parenteral drugs, validation and preparation of medicines and calculating medication dosage for healthcare professionals; development and testing of computing methods, algorithms and software; programming of data calculation and evaluation software; scientific and technological services as well as research and design services relating thereto, namely, scientific research and new product design; database design and development; hosting of computer databases for othersACTIVE—
044Advisory services relating to health; medical services in the field of public health; medical and health care services; medical care services; providing information with respect to healthACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 3, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 6, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 17, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 7, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 20, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 20, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 3, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 3, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 3, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 7, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2025RFNTREFUSAL PROCESSED BY IB—
May 21, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 21, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 26, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2025DOCKASSIGNED TO EXAMINER—
Nov 24, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 24, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 21, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance